Association of GFR-decline with serum CAF and additional clinical regressors.

a OR, odds ratio
b CI, 95% confidence interval
* Significance levels at 0.05
BMI, body mass index; eGFR T0, estimated GFR assessed by the CKD-EPI formula at baseline; PU T0, Proteinuria assessed by protein to creatinine ratio at baseline; logCAF, serum CAF levels (log-transformed). GFR, estimated glomerular filtration rate; SCreat, Serum creatinine; renin-angiotensin-aldosterone system blockade (RAAS-Block).
Association of GFR-decline with serum CAF and additional clinical regressors.

a OR：比值比（odds ratio）；b CI：95%置信区间（95% confidence interval）。* 显著性检验水准设为0.05。BMI：体质量指数（body mass index）；eGFR T0：基线时采用CKD-EPI公式估算的肾小球滤过率（estimated GFR assessed by the CKD-EPI formula at baseline）；PU T0：基线时通过尿蛋白/肌酐比值评估的蛋白尿（Proteinuria assessed by protein to creatinine ratio at baseline）；logCAF：经对数转换后的血清CAF水平（serum CAF levels (log-transformed)）。GFR：估算的肾小球滤过率（estimated glomerular filtration rate）；SCreat：血清肌酐（Serum creatinine）；肾素-血管紧张素-醛固酮系统阻断剂（renin-angiotensin-aldosterone system blockade, RAAS-Block）。肾小球滤过率下降与血清CAF及其他临床回归变量的关联分析。